Fibroblast growth factors in cardiovascular disease: The emerging role of FGF21

Early detection of risk factors for enhanced primary prevention and novel therapies for treating the chronic consequences of cardiovascular disease are of the utmost importance for reducing morbidity. Recently, fibroblast growth factors (FGFs) have been intensively studied as potential new molecules...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Am J Physiol Heart Circ Physiol
Glavni autori: Domouzoglou, Eleni M., Naka, Katerina K., Vlahos, Antonios P., Papafaklis, Michail I., Michalis, Lampros K., Tsatsoulis, Agathoklis, Maratos-Flier, Eleftheria
Format: Artigo
Jezik:Inglês
Izdano: American Physiological Society 2015
Teme:
Review
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4747916/
https://ncbi.nlm.nih.gov/pubmed/26232236
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajpheart.00527.2015
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items